21.73
전일 마감가:
$22.50
열려 있는:
$22.27
하루 거래량:
154.99K
Relative Volume:
0.82
시가총액:
$1.45B
수익:
-
순이익/손실:
$-143.59M
주가수익비율:
-7.6941
EPS:
-2.8236
순현금흐름:
$-119.47M
1주 성능:
-4.08%
1개월 성능:
-7.12%
6개월 성능:
+18.26%
1년 성능:
-9.21%
Pharvaris Nv Stock (PHVS) Company Profile
PHVS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
PHVS
Pharvaris Nv
|
21.73 | 1.45B | 0 | -143.59M | -119.47M | -2.8236 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.04 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
627.25 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.36 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
830.00 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.91 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Pharvaris Nv Stock (PHVS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-15 | 개시 | H.C. Wainwright | Buy |
| 2025-10-09 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2025-06-11 | 개시 | Guggenheim | Buy |
| 2025-04-29 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-09-25 | 개시 | Wedbush | Outperform |
| 2023-08-15 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2022-10-05 | 개시 | Bryan Garnier | Buy |
| 2022-09-13 | 재개 | JMP Securities | Mkt Outperform |
| 2022-08-23 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-22 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2022-05-25 | 개시 | JMP Securities | Mkt Outperform |
| 2021-03-02 | 개시 | BofA Securities | Neutral |
| 2021-03-02 | 개시 | Morgan Stanley | Overweight |
| 2021-03-02 | 개시 | Oppenheimer | Outperform |
| 2021-03-02 | 개시 | SVB Leerink | Outperform |
모두보기
Pharvaris Nv 주식(PHVS)의 최신 뉴스
Can Pharvaris N.V. (9EN) stock deliver strong annual returnsEarnings Risk Report & Daily Oversold Stock Bounce Ideas - newser.com
How sentiment analysis helps forecast Pharvaris N.V.July 2025 Opening Moves & Community Verified Watchlist Alerts - newser.com
Will earnings trigger a reversal in Pharvaris N.V.2025 Technical Patterns & Consistent Income Trade Recommendations - newser.com
Full technical analysis of Pharvaris N.V. stockJuly 2025 Market Mood & Momentum Based Trading Ideas - newser.com
Custom watchlist performance reports with Pharvaris N.V.Trade Risk Report & Low Risk High Reward Ideas - newser.com
Technical signs of recovery in Pharvaris N.V.July 2025 Catalysts & Weekly Chart Analysis and Guides - newser.com
What recovery options are there for Pharvaris N.V.Trade Risk Report & Free Expert Approved Momentum Trade Ideas - newser.com
Will Pharvaris N.V. stock attract ESG investorsJuly 2025 Movers & Comprehensive Market Scan Insights - newser.com
Is Pharvaris N.V. stock safe for conservative investorsMarket Sentiment Summary & Safe Entry Zone Tips - newser.com
Is Pharvaris N.V. (9EN) stock undervalued after correction2025 Market Sentiment & AI Optimized Trade Strategies - newser.com
HC Wainwright & Co. Initiates Coverage of Pharvaris N.V. (PHVS) with Buy Recommendation - MSN
Visual analytics tools that track Pharvaris N.V. performanceJuly 2025 Decliners & Low Risk High Reward Ideas - newser.com
How forex fluctuations impact Pharvaris N.V. (9EN) stockAnalyst Upgrade & Free Real-Time Market Sentiment Alerts - newser.com
Can Pharvaris N.V. (9EN) stock reach $200 price targetWeekly Trade Review & Step-by-Step Trade Execution Guides - newser.com
Can Pharvaris N.V. stock deliver sustainable ROEJuly 2025 Price Swings & AI Based Buy and Sell Signals - newser.com
How Pharvaris N.V. stock compares to market leaders2025 EndofYear Setup & Fast Momentum Entry Tips - newser.com
Cash per share of Pharvaris N.V. – BER:9EN - TradingView
Pharvaris Nv (PHVS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):